Nasal Nitric Oxide as a Novel Biomarker for Assessing Risk of Impaired Neurodevelopment in Infants and Newborns with Congenital Heart Disease
- DOI
- 10.1007/s00246-026-04454-2
- Published
- 2026-08-28
- Container
- Pediatric Cardiology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00246-026-04454-2,
title = {Nasal Nitric Oxide as a Novel Biomarker for Assessing Risk of Impaired Neurodevelopment in Infants and Newborns with Congenital Heart Disease},
author = {Emma Powers and Aaron Tien and Lauren Lorenzi-Quigley and Cecilia W. Lo and Jiuann-Huey I. Lin},
year = {2026},
journal = {Pediatric Cardiology},
doi = {10.1007/s00246-026-04454-2},
url = {https://doi.org/10.1007/s00246-026-04454-2}
}RIS
TY - JOUR TI - Nasal Nitric Oxide as a Novel Biomarker for Assessing Risk of Impaired Neurodevelopment in Infants and Newborns with Congenital Heart Disease AU - Emma Powers AU - Aaron Tien AU - Lauren Lorenzi-Quigley AU - Cecilia W. Lo AU - Jiuann-Huey I. Lin PY - 2026 JO - Pediatric Cardiology DO - 10.1007/s00246-026-04454-2 UR - https://doi.org/10.1007/s00246-026-04454-2 ER -
APA
Powers, E., Tien, A., Lorenzi-Quigley, L., Lo, C. W., & Lin, J. I. (2026). Nasal Nitric Oxide as a Novel Biomarker for Assessing Risk of Impaired Neurodevelopment in Infants and Newborns with Congenital Heart Disease. Pediatric Cardiology. https://doi.org/10.1007/s00246-026-04454-2
Source records
- crossref · retrieved 2026-09-27T13:09:48.026Z